Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid (TGC14F)

This study has been completed.
Targeted Genetics Corporation
Information provided by (Responsible Party):
International AIDS Vaccine Initiative Identifier:
First received: April 23, 2009
Last updated: December 13, 2012
Last verified: December 2012